In today’s rapidly evolving biomedical landscape, cell therapy has emerged as a major breakthrough direction and a focal point of global scientific inquiry. Against this backdrop, during the 2025 International Cell and Immunotherapy Congress (CTI 2025), Professor Shanshan Pei of Liangzhu Laboratory and the First Affiliated Hospital of Zhejiang University School of Medicine engaged in a scholarly dialogue with Dr. João Monteiro, Editor-in-Chief of Nature Medicine. 

To promote innovation in China’s cell and immunotherapy fields, deepen discussions on key scientific questions, share the latest clinical advancements, and foster global collaboration and clinical translation, the 2025 International Cell & Immunotherapy Conference (CTI 2025) was held in Hangzhou, Zhejiang, from November 13–16, 2025. The conference was jointly organized by Zhejiang University, the International Academy for Clinical Hematology (IACH), the Zhejiang Society of Immunology, and the Zhejiang Anti-Cancer Association, and was co-hosted by the First Affiliated Hospital of Zhejiang University School of Medicine and Liangzhu Laboratory.